Send Evidence, Not a Sales Pitch

What belongs in the inbox

The editorial desk welcomes corrections to claims, citation mismatches, broken source links, and newly published peer-reviewed research relevant to NAD+, NAD+ precursors, or Epitalon. The most useful message identifies the page, quotes the exact passage at issue, and supplies enough bibliographic detail to verify the proposed correction.

A clear note may flag that a cell finding was described too broadly, that a related extract was confused with the synthetic peptide, or that a human outcome was reduced to a biomarker without proper context. Those distinctions are exactly what this site exists to preserve.

Editorial mailbox: editors@wellnesspeptidestore.com

Messages are reviewed for editorial relevance. A submission does not guarantee a reply or a change, but a specific, source-backed correction gets a fair reading. Commercial placement, affiliate, product-review, and sponsored-content requests are outside the site's scope.

What the desk cannot do

This inbox is not a clinic, pharmacy, sourcing service, or adverse-event hotline. It cannot recommend a compound, assess whether a product is genuine, provide a human dose, build a cycling schedule, interpret symptoms, or decide whether any intervention is safe for a specific person. It also cannot connect readers with a seller or help obtain an unapproved research chemical.

Urgent health concerns belong with local emergency services or an appropriate licensed professional. Product-quality complaints belong with the relevant seller, manufacturer, or regulator. Questions about anti-doping status require a current check with the governing sport authority.

The boundary is blunt because the topic needs it. Published evidence can be summarized at a general level; individual decisions require clinical context that an editorial mailbox does not have. For the site's scope and method, read About. For every citation used across the digest, open References.